Hinge Health Reports Strong Q3 2025 Financial Results

Hinge Health, Inc. Class A ( (HNGE) ) has released its Q3 earnings. Here is a breakdown of the information Hinge Health, Inc. Class A presented to its investors.

Hinge Health, Inc., headquartered in San Francisco, California, is a healthcare company specializing in the automation of care delivery for musculoskeletal conditions through an AI-powered platform. The company leverages wearable devices and expert clinicians to provide personalized, evidence-based care aimed at improving patient outcomes and reducing costs for clients.

In its third-quarter 2025 earnings report, Hinge Health announced a significant milestone of surpassing 1.5 million lifetime members. The company reported a 53% year-over-year increase in revenue, reaching $154.2 million, and achieved record free cash flow. The CEO, Daniel Perez, emphasized the urgency of their mission to automate care delivery amid rising healthcare costs.

Key financial highlights from the quarter include a GAAP gross margin increase to 82% and a non-GAAP gross margin of 83%. Despite a GAAP loss from operations of $6.1 million, the company reported a non-GAAP income from operations of $30.4 million. The number of clients grew by 25% to 2,560, and the company reported net cash provided by operating activities of $82.4 million, up from $28.4 million in the previous year.

Looking ahead, Hinge Health has provided guidance for the fourth quarter of 2025, with expected revenue between $155 million and $157 million, reflecting a 33% year-over-year growth at the midpoint. The company also increased its full-year 2025 revenue guidance to between $572 million and $574 million, indicating a 47% growth at the midpoint. Management remains optimistic about driving future growth and executing strategic goals.

Overall, Hinge Health’s strong financial performance and strategic growth initiatives position the company well for continued success in the evolving healthcare landscape.